Clinical Trials Logo

Osteoarthritis of Shoulder clinical trials

View clinical trials related to Osteoarthritis of Shoulder.

Filter by:
  • None
  • Page 1

NCT ID: NCT06154694 Recruiting - Clinical trials for Osteoarthritis of Shoulder

Glenohumeral Joint Contract Patterns in Osteoarthritic Glenoids

TSA
Start date: November 3, 2021
Phase:
Study type: Observational

Shoulder osteoarthritis (OA) is a frequent problem in our aging population and is believed to occur in up to 20% of the population. Different types of glenoid morphology are associated with shoulder OA, depending on the amount and localization of the glenoid erosion as well as the amount and direction of Humeral Head Migration. Total shoulder arthroplasty (TSA) has been shown to relieve the pain and improve joint function of patients with OA. However, several complications such as component loosening and polyethylene damage has been reported and it has been revealed that 7.3% of glenoids may show signs of asymptomatic radiographic loosening annually after primary anatomic TSA. The mechanism of such fixation failure is still unclear. The main goal of this study is evaluating in-vivo glenohumeral contact patterns in patients with osteoarthritic glenoids before and after TSA, to unravel the high rate of glenoid component loosening.

NCT ID: NCT03921944 Recruiting - Clinical trials for Osteoarthritis of Shoulder

Evaluation of Structural and Functional Integrity of the Rotator Cuff After Total Shoulder Arthroplasty

Start date: May 2, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the rotator cuff muscles in your shoulder at one and two year post total shoulder replacement surgery.

NCT ID: NCT00377624 Completed - Clinical trials for Osteoarthritis of Shoulder

HUPS: Hyalgan Use in Painful Shoulder

Start date: January 2002
Phase: Phase 3
Study type: Interventional

Three-arm, parallel, double-blind, masked observer, randomized, PB-Saline controlled clinical trial. In order to avoid problems in the interpretation of the final results due to disparate enrollment from various centers, the number of patients enrolled per site will be the same per site. Study patients will be randomized to receive either 20 mg sodium hyaluronate, 3 i.a. sodium hyaluronate injections, followed by 2 PBSaline mock i.a. injections or 5 i.a. PB-Saline control injections. One investigator will administer the injection and the joint assessor will be blinded to the study. The anterior or posterior approach for the shoulder injection will be used.